ATE219100T1 - 17-beta-cyclopropyl(amino/oxy)4-aza steroide als testosterone 5-alpha-rectase und c17-20-lyase hemmende verbindungen - Google Patents

17-beta-cyclopropyl(amino/oxy)4-aza steroide als testosterone 5-alpha-rectase und c17-20-lyase hemmende verbindungen

Info

Publication number
ATE219100T1
ATE219100T1 AT97901995T AT97901995T ATE219100T1 AT E219100 T1 ATE219100 T1 AT E219100T1 AT 97901995 T AT97901995 T AT 97901995T AT 97901995 T AT97901995 T AT 97901995T AT E219100 T1 ATE219100 T1 AT E219100T1
Authority
AT
Austria
Prior art keywords
alpha
beta
compounds
androgen
aza
Prior art date
Application number
AT97901995T
Other languages
English (en)
Inventor
James R Pribish
Cynthia A Gates
Philipp M Weintraub
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE219100T1 publication Critical patent/ATE219100T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97901995T 1996-02-14 1997-01-09 17-beta-cyclopropyl(amino/oxy)4-aza steroide als testosterone 5-alpha-rectase und c17-20-lyase hemmende verbindungen ATE219100T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60127896A 1996-02-14 1996-02-14
PCT/US1997/000469 WO1997030069A1 (en) 1996-02-14 1997-01-09 17-beta-cyclopropyl(amino/oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20-lyase

Publications (1)

Publication Number Publication Date
ATE219100T1 true ATE219100T1 (de) 2002-06-15

Family

ID=24406899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97901995T ATE219100T1 (de) 1996-02-14 1997-01-09 17-beta-cyclopropyl(amino/oxy)4-aza steroide als testosterone 5-alpha-rectase und c17-20-lyase hemmende verbindungen

Country Status (17)

Country Link
EP (1) EP0880540B1 (de)
JP (1) JP2000505444A (de)
KR (1) KR19990082543A (de)
CN (1) CN1211256A (de)
AT (1) ATE219100T1 (de)
AU (1) AU710208B2 (de)
BR (1) BR9708301A (de)
CA (1) CA2244823A1 (de)
DE (1) DE69713285T2 (de)
DK (1) DK0880540T3 (de)
ES (1) ES2178750T3 (de)
HU (1) HUP9900955A3 (de)
IL (1) IL125575A0 (de)
NO (1) NO983724L (de)
NZ (1) NZ327041A (de)
PT (1) PT880540E (de)
WO (1) WO1997030069A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187925B1 (en) 1997-12-23 2001-02-13 Merck & Co., Inc. Intermediates and process for the synthesis of azasteroids
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
EP1348706B1 (de) 2000-12-08 2009-08-19 Takeda Pharmaceutical Company Limited Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung
CA2524409C (en) 2003-05-07 2011-12-20 Merck & Co., Inc. Androgen receptor modulators and methods of use thereof
RU2481107C2 (ru) * 2007-10-29 2013-05-10 Такеда Фармасьютикал Компани Лимитед Средство для профилактики или лечения рака
JP2012506906A (ja) * 2008-10-28 2012-03-22 バイオマリン ファーマシューティカル インコーポレイテッド デカヒドロ−1h−インデノキノリンおよびデカヒドロ−3h−シクロペンタフェナントリジノンcyp17インヒビター
WO2011088160A2 (en) * 2010-01-15 2011-07-21 Biomarin Pharmaceutical Inc. Novel cyp17 inhibitors
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic
CN109438549B (zh) * 2018-12-13 2022-01-04 湖北葛店人福药业有限责任公司 一种制备N-叔丁基-3-氧代-4-氮杂-5α-雄甾-17β-甲酰胺的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264427A (en) * 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
EP0641211A1 (de) * 1992-05-21 1995-03-08 Endorecherche Inc. Testosteron-5-alpha-reduktase-inhibitonen
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase

Also Published As

Publication number Publication date
AU710208B2 (en) 1999-09-16
NZ327041A (en) 1999-11-29
JP2000505444A (ja) 2000-05-09
HUP9900955A3 (en) 2000-06-28
DK0880540T3 (da) 2002-10-07
DE69713285D1 (en) 2002-07-18
HUP9900955A2 (hu) 1999-07-28
PT880540E (pt) 2002-10-31
DE69713285T2 (de) 2003-01-02
KR19990082543A (ko) 1999-11-25
CA2244823A1 (en) 1997-08-21
NO983724D0 (no) 1998-08-13
ES2178750T3 (es) 2003-01-01
AU1576797A (en) 1997-09-02
BR9708301A (pt) 1999-08-03
EP0880540B1 (de) 2002-06-12
EP0880540A1 (de) 1998-12-02
IL125575A0 (en) 1999-03-12
WO1997030069A1 (en) 1997-08-21
NO983724L (no) 1998-10-13
CN1211256A (zh) 1999-03-17

Similar Documents

Publication Publication Date Title
ATE368466T1 (de) Androgensyntheseinhibitoren
GEP20125397B (en) Helix 12 directed non-steroidal antiandrogens
ATE219100T1 (de) 17-beta-cyclopropyl(amino/oxy)4-aza steroide als testosterone 5-alpha-rectase und c17-20-lyase hemmende verbindungen
BR0006265A (pt) Composto de tetrahidroisoquinolinas como agonistas/antagonistas de estrogênios
DE60332445D1 (de) Neue curcuminanaloga und deren anwendungen
KR950701527A (ko) 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
KR910004651A (ko) 5α-환원효소 억제제로서의 17β-아실-4-아자-5α-안드로스트-1-엔-3-온
DK1084569T3 (da) Androgener i kombination med gestagener til udligning af et testosteronunderskud med beskyttelse af prostata
ATE315033T1 (de) Subtituierte isoxazole derivate als estrogen rezeptor modulatore
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
BRPI0506470A (pt) produtos farmacêuticos esteroidal direcionado a helix 12, incluindo composto molecular da fórmula ou sal do mesmo; composição farmacêutica e método de tratamento
DE60045751D1 (de) Therapeutische Behandlung androgenrezeptorbedingter Leiden
ATE186913T1 (de) 17-substituierte steroide, verwendbar bei behandlung von krebs
ATE264304T1 (de) Dihydronaphthalinderivate und verfahren zur herstellung derselben
IL126328A0 (en) 7 alpha-(5-Methylaminopentyl)-estratrienes pharmaceutical preparations containing the same and use thereof
MXPA03002495A (es) Proceso para preparacion de compuestos de n-(fenil sustituido)-3-alquil, aril- y heteroarilsulfonil-2-hidroxi-2-alquil- y haloalquilpropanamida.
Morzycki et al. Synthesis of 4, 17-diazasteroid inhibitors of human 5α-reductase
HUP0302405A2 (hu) Új benzofuránszármazékok
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
ATE339415T1 (de) Benzocarbazol und indenoindole derivate als östrogene agentien
MX9705145A (es) Agonistas/antagonistas de estrogenos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0880540

Country of ref document: EP

REN Ceased due to non-payment of the annual fee